Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2008
11/25/2008US7456014 Expression vector for use as regulatory tool in genetic engineering; useful for reducing the expression of endogenous mRNA and any substantially similar endogenous mRNA
11/25/2008US7456013 Minichromosomes for use as vectors in plant and animal transformations; artificial chromosomes; autonomous replicating sequences (ars)
11/25/2008US7456003 Isolated protein having the enzymatic activity of an amylosucrase produced by recombinant DNA
11/25/2008US7456002 Mutant poly(3-hydroxyalkanoic acid) synthases
11/25/2008US7456001 A polynucleotide encoding a lipoxygenase and its use for recombinant production of a lipoxygenase; obtaining a lipoxygenase by screening a DNA library with specific probes
11/25/2008US7455996 From sucrose and galactinol; biosynthesis; chromatography; electrophoresis
11/25/2008US7455993 Cytokine protein family
11/25/2008US7455991 Serpentine transmembrane antigens expressed in human cancers and uses thereof
11/25/2008US7455990 Isolating hexose oxidase for use as tool in enhancement of nutrient quality of animal feeeds
11/25/2008US7455988 Nucleotide sequences; genetic engineering; controller fusion protein; blocking transcription
11/25/2008US7455974 Collection of nucleic acid fragments resulting from complete digestion of one or more nucleic acids by one or more restriction endonucleases; contains at least 3 fragments; and the size of the fragments in base pairs is a multiple of an integer of 10 or more
11/25/2008US7455972 Determining presence, absence or quantity of murine Norovirus-1 (MNV-1) in a murine tissue, organ or feces sample by synthesizing complementary DNA from the sample RNA and detecting MNV-1 cDNA if present by a Polymerase chain reaction if MNV-1
11/25/2008US7455971 Multiplex decoding of array sensors with microspheres
11/25/2008US7455970 Identifying a subject predisposed to ischemic stroke by determining the presence of a cytosine to thymine mutation at position -7351 of the upstream region of tissue plasminogen activator locus, which reduces the release rate of tissue plasminogen activator from endothelial cells into the circulation
11/25/2008US7455969 Highly permissive cell lines for hepatitis C virus RNA replication
11/25/2008US7455968 Detection method
11/25/2008US7455966 System and method for detecting a biological entity in a water sample
11/25/2008CA2361318C Novel nucleosides and oligonucleotide analogues
11/25/2008CA2345354C Antisense modulation of bcl-x expression
11/25/2008CA2223078C Nucleic acid ligands that bind to and inhibit dna polymerases
11/20/2008WO2008141308A2 Gene expression and pain
11/20/2008WO2008141289A1 Silver nanoparticle binding agent conjugates based on moieties with triple cyclic disulfide anchoring groups
11/20/2008WO2008140812A2 Compositions and methods comprising klk3, psca, or folh1 antigen
11/20/2008WO2008140622A2 Modified polymerases and attenuated viruses and methods of use thereof
11/20/2008WO2008140538A1 Dna display screen for expression product with desired binding properties
11/20/2008WO2008140532A1 Method of detecting bladder urothelial carcinoma
11/20/2008WO2008140513A1 Nucleic acid primers and probes for detecting human and avian influenza viruses
11/20/2008WO2008139262A2 Oligoribonucleotides and uses thereof
11/20/2008WO2008138189A1 Use of cthrc1 in diagnosing cancer of liver
11/20/2008WO2008121963A3 Compositions and methods for gene silencing
11/20/2008WO2008116220A3 Methods and compositions related to riboswitches that control alternative splicing
11/20/2008WO2008116094A3 Combined hairpin-antisense compositions and methods for modulating expression
11/20/2008WO2008115470A3 Hox-gene expression as a biomarker for igf-1r therapeutics
11/20/2008WO2008112008A9 Sensor proteins and assay methods
11/20/2008WO2008109463A3 Red-shifted luciferase
11/20/2008WO2008103770A3 Multiplex compositions and methods for quantification of human nuclear dna and human male dna and detection of pcr inhibitors
11/20/2008WO2008100749A3 Transfection in magnetically driven continuous flow
11/20/2008WO2008098159A3 Genetic marker for risk of cardiovascular disorder
11/20/2008WO2008095152A3 Methods and materials for identifying the origin of a carcinoma of unknown primary origin
11/20/2008WO2008094678A3 A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
11/20/2008WO2008091276A3 Use of chick beta actin gene intron-1
11/20/2008WO2008089108A3 Sire early selection for male fertility using single nucleotide polymorphisms (snps) of the dazl gene
11/20/2008WO2008088863A9 Stem cell gene targeting
11/20/2008WO2008076987A3 Genes encoding fatty acid desaturases from sorghum bicolor
11/20/2008WO2008076375A3 Concurrent analysis of multiple patient samples using solid phase addressable multiplex test with high signal-to-noise ratio
11/20/2008WO2008076374A3 Devices and methods of anonymously deconvoluting combined patient samples and combined patient assays
11/20/2008WO2008070344A3 Compositions and methods for binding sphingosine-1-phosphate
11/20/2008WO2008070296A3 System and method for diagnosis and treatment of neuropsychiatric disorders
11/20/2008WO2008070179A3 Genes and uses for plant improvement
11/20/2008WO2008070082A3 Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
11/20/2008WO2008069940A3 Multi-microrna methods and compositions
11/20/2008WO2008048334A3 Materials and methods for the detection of anthrax related toxin genes
11/20/2008WO2008043033A3 Fibrillation-resistant insulin and insulin analogues
11/20/2008WO2008036127A3 Oligonucleotide analogs having cationic intersubunit linkages
11/20/2008WO2008033866A3 Methods and compositions for the use of lysine riboswitches
11/20/2008WO2008030613A3 Hybrid suppressor trna for vertebrate cells
11/20/2008WO2008011170A3 Methods for detecting the presence of expanded cgg repeats in the fmr1 gene 5' untranslated region
11/20/2008WO2008008501A3 Reverse restriction fragment length polymorphism assay and uses thereof
11/20/2008WO2008005562A3 Rna silencing compositions and methods for the treatment of huntington's disease
11/20/2008WO2008002920A3 Methods for generating target nucleic acid sequences
11/20/2008WO2007145992A3 Genetic basis of treatment response in depression patients
11/20/2008WO2007143037A3 Gene methylation in cancer diagnosis
11/20/2008WO2007131071A3 Mig-7 as a specific anticancer target
11/20/2008WO2007127830A3 Dep2 and its uses in major depressive disorder and other related disorders
11/20/2008WO2007120843A3 Single nucleotide polymorphism detection from unamplified genomic dna
11/20/2008WO2007120541A3 Method for cloning and expression of nrui restriction endonuclease
11/20/2008WO2007098379A3 Methods of extracting nucleic acids
11/20/2008WO2006130829A3 Altered zdhhc8 expression as a marker of increased risk of schizophrenia
11/20/2008WO2006121569A3 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/20/2008WO2006062647A3 Gene expression and genetic changes implicated in alcoholism
11/20/2008WO2005089527A3 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores
11/20/2008WO2004030615A8 Compositions and methods for the diagnosis and treatment of tumor
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080289062 Sorghum aluminum tolerance gene, SbMATE
11/20/2008US20080289060 Herbicide tolerant rice plants and methods for identifying same
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080288177 Pharacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis
11/20/2008US20080287671 2'(3')-O-((Phenylaminocarbonyl)-uridine 5'-)triphosphate, for example; useful in preventing thrombosis and restenosis, effective in inhibiting the contraction of vascular smooth muscle cells, inhibiting cell proliferation, and reducing inflammation
11/20/2008US20080287670 Systems and methods for the purification of synthetic trityl-on oligonucleotides
11/20/2008US20080287668 Nanostructures and methods of making
11/20/2008US20080287667 Nucleic Acid Labeling Compounds
11/20/2008US20080287666 Detecting nucleic acid strands and inter-substance binding or interaction detecting method
11/20/2008US20080287665 CANINE IgG NUCLEIC ACID MOLECULES
11/20/2008US20080287652 Antagonists Against Interaction of Pf4 and Rantes
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287385 Inhibitor oligonucleotides and their use for specific repression of a gene
11/20/2008US20080287383 Nucleic acid compounds for inhibiting erbb gene expression and uses thereof
11/20/2008US20080287380 Antisense Oligonucleotides Against Cpla2, Compositions and Uses Thereof
11/20/2008US20080287379 Oligonucleotide Complex Compositions and Methods of Use as Gene Alteration Tools
11/20/2008US20080287364 Bitter Taste Receptors
11/20/2008US20080287363 Isolated from the saliva of Rhipicephalus sanguineus; antiinflammatory and immunomodulatory compounds; antagonists of CCL5 and CCL11
11/20/2008US20080287362 Compositions and Methods for the Detection of Trypanosoma Cruzi Infection
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287349 Fibroblast growth factor 20 and methods of use thereof
11/20/2008US20080287348 Soluble Hybrid Prion Proteins And Their Use In The Diagnosis, Prevention And Treatment Of Transmissible Spongiform Encephalopathies
11/20/2008US20080287318 Primers and Probes for Detecting Genital Hpv Genotypes
11/20/2008US20080287312 Probe, probe set, probe carrier, and testing method
11/20/2008US20080287311 Membrane-Translocating Peptides
11/20/2008US20080286878 Systems, Compositions And Methods For Nucleic Acid Detection
1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 899